DORADO, PR / ACCESS Newswire / January 29, 2026 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a regulatory affairs, quality, compliance, project management and technology transfer support consulting firm that provides services to the pharmaceutical, biotechnology, medical device, cosmetic, food and allied products industries, today announced that revenues for the year ended October 31, 2025 were approximately $9.0 million, a decrease of approximately $0.5 million when compared t ...

Core Insights - Pharma-Bio Serv, Inc. reported revenues of approximately $2.0 million for the three months ended July 31, 2025, a decrease from $2.4 million in the same period of 2024 [1] - For the nine months ended July 31, 2025, revenues were approximately $6.9 million, down from $7.2 million for the same period in 2024 [1] Revenue Analysis - The revenue for the three months ended July 31, 2025, decreased by approximately 16.67% compared to the same period in 2024 [1] - The revenue for the nine months ended July 31, 2025, decreased by approximately 4.17% compared to the same period in 2024 [1]